- Pharmacy
- Company
Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals
In addition, the anticipated expansion of gene therapies will increase provider spend even more.
- Pharmacy
- Operations & Quality
Vizient Provides Feedback to FDA on Quality Management Maturity for Drug Manufacturing Establishments
Vizient, Inc. submitted comments to the Food and Drug Administration on the development of a program aimed at promoting drug manufacturers’ quality management maturity.
- Operations & Quality
- Data & Analytics
- Pharmacy
For Pediatric Patient Population, Vizient Forecasts Growth in Obesity Services, Highlights Risk Factors for Asthma and Examines New RSV Vaccines
The latest Pediatric Tech Watch shares new information for the care of this vulnerable patient population.
- Pharmacy
Vizient: Lack of Information Across Supply Chain Exacerbating Oncology Drug Shortage
A Vizient white paper demonstrates how the lack of information about medication access across the supply chain is exacerbating the shortage of seven oncology drugs used to treat a multitude of cancers.
- Company
- Pharmacy
Vizient: Expansion of Specialty Drugs Driving a 3.42% Projected Increase in Hospital Pharmacy Spend
Vizient, Inc. projects a 3.42% increase in hospital pharmaceutical spend in its Summer Pharmacy Market Outlook, released July 31.
- Pharmacy
Vizient to Share Insights on Biosimilars at Festival of Biologics
Vizient, Inc. announced today that Steven Lucio, PharmD, BCPS, senior principal, pharmacy solutions for Vizient, will share insights on biosimilars in the panel discussion, "Building the Sustainable Future of Biosimilars".
- Company
- Pharmacy
Drug Inflation Rate Continues Upward Trend at 3.78%: Vizient Pharmacy Market Outlook
Vizient, Inc. released its Winter 2023 Pharmacy Market Outlook, forecasting a 3.78% overall drug price inflation rate for the calendar year beginning, July 1, 2023.
- Company
- Pharmacy
Vizient Endorses Legislation to Make Biosimilars More Accessible
This week, Vizient, Inc. offered support for the Biologics Competition Act of 2022, H.R. 8877. This important bipartisan legislation would strengthen the healthcare market by minimizing barriers to the substitution of interchangeable biological products an...
- Pharmacy
Vizient Pharmacy Leaders to Speak at FDA’s Compounding Quality Center of Excellence Annual Conference
Vizient, Inc. pharmacy experts, including Pharmacy Executive Director Carolyn Liptak and Pharmacy Contracting Director April Yoo, will present at the Food and Drug Administration's (FDA)
- Pharmacy
New Survey from Vizient Provides Hospital Insights into Biosimilar Adoption and What is Preventing Greater Utilization
The survey of hospital leaders and pharmacy professionals from Vizient member hospitals across the country found that biosimilars are gaining inclusion in hospital formularies, something long seen as a necessity for greater adoption.
- Pharmacy
Vizient Projects 3.26% Drug Price Inflation Rate for 2023 in Latest Pharmacy Market Outlook
Vizient, Inc. released its Summer 2022 Pharmacy Market Outlook forecasting a 3.26% overall drug price inflation rate for the calendar year beginning Jan. 1, 2023. The rate reflects a continued trend toward moderation of the overall increase in drug prices,...
- Pharmacy
Vizient Pharmacy Market Outlook: Increased Use of Remdesivir for COVID Pushes it to Top Spot in Total Vizient Member Spend
The finding is reported in the Vizient Winter 2022 Pharmacy Market Outlook, which forecasts an overall 3.09% increase in drug prices for July 1, 2022 through June 30, 2023.
- Pharmacy
- Company
Vizient Calls on Industry Stakeholders to Join Alliance to End Drug Shortages
The number of active drug shortages in the U.S. has remained above 200 since 2017. As a result, patients and prescribers in the U.S. face disruption in accessing medications, sometimes impacting life-saving care. The End Drug Shortages Alliance will provid...
- Pharmacy
Vizient Announces Milestone in Fight to End Drug Shortages: 100 Million Additional Units of Essential Medications Through Novaplus Enhanced Supply Program in Under Two Years
Vizient announces its Novaplus Enhanced Supply Program has brought 100 million additional units of essential medication inventory to the supply chain.
- Pharmacy
New Vizient Data Estimates US Hospitals Spend $310 Million Annually on Management of 'White/Brown Bagging' Requirements for Specialty Pharmaceuticals
Vizient released an analysis which estimates U.S. hospitals are spending $310 million annually to manage additional work of white and brown bagging.
- Pharmacy
Vizient Announces New Member Agreement with The University of Texas System
Vizient announces a new agreement with The University of Texas System that expands services and solutions for delivery of cost effective care.
- Pharmacy
Vizient Pharmacy Market Outlook Forecasts 3.10% Increase in Drug Spend, Reveals Impact of COVID on Hospital Pharmacy Purchases
While the report, an analysis of Vizient member pharmaceutical purchase data, forecasts that oncology will remain the top therapeutic class in spend by Vizient member purchases, it also projects COVID-19 to have a pronounced effect on member drug purchases...
- Pharmacy
Vizient Adds New Essential Medications and Products to its Novaplus Enhanced Supply Program
Vizient announces the expansion of its Novaplus Enhanced Supply Program portfolio, adding six essential medications and two types of thermometers.
- Pharmacy
Vizient Forecasts 2.67% Increase in Drug Spend in New Pharmacy Market Outlook; Impact of COVID-19 Continues to be Felt Across Healthcare Ecosystem
Vizient released its Winter 2021 Pharmacy Market Outlook, projecting a 2.67% increase in the price of pharmaceuticals for July 1- June 30, 2022.
- Pharmacy
Vizient Forecasts 2.67% Increase in Drug Spend in New Pharmacy Market Outlook; Impact of COVID-19 Continues to be Felt Across Healthcare Ecosystem
Formerly named the Drug Price Forecast, the Outlook’s projected increase continues to trend slightly downward, reflecting recent generic entrants to the market as well as increasing adoption of biosimilars.
- Pharmacy
Vizient Forecasts 2.67% Increase in Drug Spend in New Pharmacy Market Outlook; Impact of COVID-19 Continues to be Felt Across Healthcare Ecosystem
Vizient released its Winter 2021 Pharmacy Market Outlook, projecting a 2.67% increase in the price of pharmaceuticals for July 1 – June 30, 2022.
- Company
- Pharmacy
Vizient Offers Comments to FDA on List of Essential Medicines, Medical Countermeasures and Critical Inputs
Vizient submits comments to the FDA applauding its efforts to publish a list of essential medicines, medical countermeasures and critical inputs.
- Pharmacy
Vizient Announces Novaplus Enhanced Supply Agreement with Pfizer for 7 Additional Essential Medications
Vizient announced an agreement with Pfizer to add 7 essential medications to Novaplus Enhanced Supply, Vizient’s private label pharmacy solution.
- Pharmacy
Vizient Analysis Shows Ending Unapproved Drugs Initiative Could Save Between $7.52 Billion and $26.59 Billion
Vizient releases updated analysis showing ending the FDA's Unapproved Drugs Initiative could save hospitals between $7.52 billion and $26.59 billion.
